Remove 2022 Remove Hospice Remove Medicare Remove Personal care
article thumbnail

Addus Orients M&A Strategy Away From Hospice, Towards Home Health, Personal Care

Hospice News

Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its home health and personal care businesses. Texas-based Addus provides personal, home health and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.

article thumbnail

Aetna’s President of Medicare: MA Plans Go All-In on Aging in Place with New 2024 Benefits, Palliative Care, Hospice VBID

Hospice News

Aetna, a subsidiary of CVS Health (NYSE: CVS), is leveraging a series of new benefits that, coupled with existing palliative care programs and ongoing hospice payment demonstrations, promise to keep patients in their homes and out of facilities. Patients can access palliative care through a number of inroads.

2024 274
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

Hospice News

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.

article thumbnail

Addus Sees Hospice Improvements, Plans to Rebalance Home Health-Personal Care M&A Activity

Hospice News

Addus HomeCare Corporation’s (NASDAQ: ADUS) hospice segment is seeing slow but steady improvement as pandemic headwinds ease. Meanwhile, the company’s near-term acquisition sights are set more on home health than in personal care amid potential payment shifts. We believe that hospice volumes will continue to steadily improve.”

article thumbnail

Hospice Investors to Watch in 2024

Hospice News

Though the number of hospice M&A deals plummeted in 2023 compared to prior years, deals are still being made, and the industry may see a rebound in 2024. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. This followed its $5.4 NYSE: HUM) for $2.8

2024 245
article thumbnail

High Price Tags Pushing Addus Away from Hospice Acquisitions

Hospice News

High valuations have led Addus HomeCare (NASDAQ: ADUS) to pivot towards personal care and home health deals rather than hospice acquisitions. Hospice multiples broke records in 2020, 2021 and 2022, reaching as high as 29x. Hospice is still very expensive. Addus began as a personal care provider in 1979.

Hospice 218
article thumbnail

Value-Based Care: What Hospices Can Learn from Home Health Companies

Hospice News

When it comes to value-based payment models, home health has a head start on hospice. But those providers’ experiences can lend some insights into how hospices can prepare themselves. Hospices are only now taking their first steps into value-based reimbursement. But starting in 2022, CMS began rolling it out nationwide.

Hospice 227